| Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors F Tas Journal of Oncology 2012 (647684), 1-9, 2012 | 338 | 2012 |
| Oxidative stress in breast cancer F Tas, H Hansel, A Belce, S Ilvan, A Argon, H Camlica, E Topuz Medical Oncology 22 (1), 11-16, 2005 | 215 | 2005 |
| Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms A Aydiner, A Karadeniz, K Uygun, S Tas, F Tas, R Disci, E Topuz American Journal of Clinical Oncology 23 (4), 364-370, 2000 | 212 | 2000 |
| Anemia in oncology practice: relation to diseases and their therapies F Tas, Y Eralp, M Basaran, B Sakar, S Alici, A Argon, G Bulutlar, ... American Journal of Clinical Oncology 25 (4), 371-379, 2002 | 186 | 2002 |
| Age is a prognostic factor affecting survival in lung cancer patients F Tas, R Ciftci, L Kilic, S Karabulut Oncology Letters 6 (5), 1507-1513, 2013 | 174 | 2013 |
| Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease F Tas, F Aykan, S Alici, E Kaytan, A Aydiner, E Topuz American Journal of Clinical Oncology 24 (6), 547-550, 2001 | 124 | 2001 |
| The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients F Tas, Z Ustuner, G Can, Y Eralp, H Camlica, M Basaran, H Karagol, ... Acta oncologica 44 (2), 161-167, 2005 | 121 | 2005 |
| Clinical and prognostic significance of coagulation assays in lung cancer F Tas, L Kilic, M Serilmez, S Keskin, F Sen, D Duranyildiz Respiratory Medicine 107 (3), 451-457, 2012 | 117 | 2012 |
| Performance status of patients is the major prognostic factor at all stages of pancreatic cancer F Tas, F Sen, H Odabas, L Kılıc, S Keskın, I Yıldız International Journal of Clinical Oncology 18 (5), 839-846, 2012 | 114 | 2012 |
| Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer F Tas, D Duranyildiz, A Argon, H Oğuz, H Camlica, V Yasasever, E Topuz Medical Oncology 22 (4), 353-358, 2005 | 105 | 2005 |
| Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer D Derin, HO Soydinç, N Guney, F Tas, H Çamlıca, D Duranyıldız, ... Lung Cancer 59 (2), 240-245, 2008 | 101 | 2008 |
| Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature S Kurul, F Tas, N Büyükbabani, A Mudun, C Baykal, H Çamlıca Japanese Journal of Clinical Oncology 35 (4), 202-206, 2005 | 94 | 2005 |
| Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients F Tas, D Duranyildiz, H Oguz, H Camlica, V Yasasever, E Topuz Melanoma Research 16 (5), 405-411, 2006 | 90 | 2006 |
| Serum IL-8 and IL-12 levels in breast cancer D Derin, HO Soydinc, N Guney, F Tas, H Camlica, D Duranyildiz, ... Medical Oncology 24 (2), 163-168, 2007 | 84 | 2007 |
| Granulosa cell tumor of the ovary: retrospective analysis of 45 cases K Uygun, A Aydiner, P Saip, M Basaran, F Tas, Z Kocak, M Dincer, ... American Journal of Clinical Oncology 26 (5), 517-521, 2003 | 83 | 2003 |
| Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer F Tas, D Duranyildiz, H Oguz, H Camlica, V Yasasever, E Topuz Cancer Investigation 24 (5), 492-496, 2006 | 82 | 2006 |
| Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer F Tas, A Aydiner, C Demir, E Topuz American Journal of Clinical Oncology 24 (4), 376-378, 2001 | 80 | 2001 |
| Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer F Tas, D Duranyildiz, H Oguz, H Camlica, V Yasasever, E Topuz Cancer Investigation 24 (6), 576-580, 2006 | 71 | 2006 |
| Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer F Tas, S Karabulut, M Serilmez, R Ciftci, D Duranyildiz Tumor Biology 35 (4), 3125-3132, 2014 | 69 | 2014 |
| Prognostic factors in metastatic pancreatic cancer: older patients are associated with reduced overall survival F Tas, F Sen, S Keskin, L Kilic, I Yildiz Molecular and Clinical Oncology 1 (4), 788-792, 2013 | 69 | 2013 |
